Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
ACE Reports.
Peri-Operative
Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized Study.
J Bone Miner Res. 2023 01-Oct;():. 10.1002/jbmr.4877
Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized Study.
J Bone Miner Res. 2023 01-Oct;():. 10.1002/jbmr.4877
General Orthopaedics
The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial
J Bone Miner Res. 2022 01-Dec;():. 10.1002/jbmr.4719
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
The Efficacy and Safety of Abaloparatide-SC in Men With Osteoporosis: A Randomized Clinical Trial
J Bone Miner Res. 2022 01-Dec;():. 10.1002/jbmr.4719
Metabolic Disorders
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
N Engl J Med. 2016 Oct 20;375(16):1532-1543
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Romosozumab Treatment in Postmenopausal Women with Osteoporosis
N Engl J Med. 2016 Oct 20;375(16):1532-1543
General Orthopaedics
Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial
Osteoporos Int. 2014 Nov;25(11):2649-56
Efficacy and safety of oral recombinant calcitonin tablets in postmenopausal women with low bone mass and increased fracture risk: a randomized, placebo-controlled trial
Osteoporos Int. 2014 Nov;25(11):2649-56